FMT Treating Constipation Patients With Depression and/or Anxiety Symptoms - Clinical Efficacy and Potential Mechanisms
NCT ID: NCT03233100
Last Updated: 2017-07-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
40 participants
INTERVENTIONAL
2017-07-30
2018-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study of the Efficacy of Fecal Microbiota Transplantation(FMT) in the Treatment of Depression
NCT05850572
Effect of Probiotic on Comorbidity of Depression and Constipation
NCT04570072
The Safety and Efficacy of Fecal Microbiota Transplantation in a Population With Major Depressive Disorder
NCT04805879
Intestinal Flora and Major Depressive Disorders
NCT04347577
Poststroke Depression of Clinical Trial Registration
NCT03863951
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
FMT group
FMT
fecal microbiota transplantation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
FMT
fecal microbiota transplantation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age ≥ 18 years
* Body mass index of 18-25 kg/m2.
* HAMA ≥ 14 and/or HAMD (17 items) ≥ 17
Exclusion Criteria
* History of organic intestinal disorders
* History of gastrointestinal surgery
* Pregnant or breast-feeding women
* Infection with enteric pathogen
* Usage of probiotics, prebiotics, antibiotics within the last month
* Uncontrolled hepatic, renal, cardiovascular, and respiratory, or any diseases that in the opinion of the investigator, could affect intestinal transit and the intestinal microbiota.
* Patients who could not complete the follow-up
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Jianfeng Gong
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jianfeng Gong
Professor, Associate senior doctor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Generay Surgery, Jinling hosptal, Medical School of Nanjing University
Nanjing, Jiangsu, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STC-D-A-2017-FMT
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.